Multi-institutional report on toxicities of concurrent nivolumab and radiation therapy

PURPOSE: Radiation therapy (RT) and nivolumab are standard therapies for a wide range of advanced and metastatic cancers, yet little is known about the toxicity profile of their combined treatment. The rate of grade ≥3 toxicities from nivolumab monotherapy and radiation-only palliative treatments ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Neha P., Zainib, Maliha, Parker, Sean M., Agarwal, Manuj, Mattes, Malcolm D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Toxicity Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128090/
https://www.ncbi.nlm.nih.gov/pubmed/30202808
http://dx.doi.org/10.1016/j.adro.2018.04.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128090/
https://www.ncbi.nlm.nih.gov/pubmed/30202808
http://dx.doi.org/10.1016/j.adro.2018.04.015

Ejemplares similares